{{Rsnum
|rsid=13329835
|Gene=CDYL2
|Chromosome=16
|position=80616908
|Orientation=plus
|GMAF=0.2897
|Gene_s=CDYL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.5 | 32.7 | 1.8
| HCB | 92.0 | 7.3 | 0.7
| JPT | 95.6 | 4.4 | 0.0
| YRI | 6.8 | 34.2 | 58.9
| ASW | 22.8 | 42.1 | 35.1
| CHB | 92.0 | 7.3 | 0.7
| CHD | 87.2 | 11.9 | 0.9
| GIH | 84.2 | 13.9 | 2.0
| LWK | 8.2 | 39.1 | 52.7
| MEX | 79.3 | 19.0 | 1.7
| MKK | 11.7 | 46.8 | 41.6
| TSI | 52.9 | 39.2 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=G
  |Pval=2E-16
  |OR=1.08
  |ORtxt=[1.05-1.10]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}